 |
|
Tony Coulepis
Chief Executive Officer
Dr Anthony (Tony) Coulepis currently holds a number of positions including:
- CEO of Alexanders Securities Limited, a publicly listed company (ASX:ALE);
- CEO of Stem Cell Healthcare & Technologies Limited;
- CEO of Cell Sense Pty Ltd;
- The Strategic Industry Advisor of Innovation Dynamics Pty Ltd;
- A non-Executive Director of Medical Developments International Pty Ltd, an Australian publicly listed company (ASX:MVP);
- The Industry Advisor of Box Hill Institute; and
- A member of a number of other Advisory positions within the biotechnology and life science industry.
Prior to being appointed to the above positions, Tony was the “founding” Executive Director and CEO of the Australian Biotechnology Association’s (ABA), which he transformed to become AusBiotech Ltd, Australia’s peak biotechnology industry organisation. Tony developed and implemented AusBiotech’s first Business Plan, titled, “Growing Australian Biotechnology” and also developed the organisation’s second Business Plan, titled, “Globalising Australian biotechnology”.
Tony has over 25 years of experience in the biotechnology and life sciences industries and graduated with a Ph.D in microbiology from Monash University, specialising in Virology (Hepatitis A).
Tony is the author of more than 70 scientific and industry publications and can be contacted at tony.coulepis@cellsense.com.au.
|